Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Lifted by Bensler LLC

Bensler LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 23.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,105 shares of the medical equipment provider's stock after buying an additional 583 shares during the period. Bensler LLC's holdings in Intuitive Surgical were worth $1,538,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Global Financial Private Client LLC raised its position in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares during the last quarter. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In other news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president now directly owns 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Down 0.2%

ISRG traded down $0.82 during trading on Friday, hitting $512.18. 2,181,892 shares of the company's stock were exchanged, compared to its average volume of 1,672,886. The firm has a market cap of $183.57 billion, a P/E ratio of 79.90, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. The stock has a 50 day moving average price of $525.48 and a 200 day moving average price of $538.67. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the firm earned $1.50 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Piper Sandler dropped their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Royal Bank of Canada dropped their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the stock from $515.00 to $440.00 in a research report on Monday. Finally, Barclays dropped their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and an average target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.